Grandfield & Dodd LLC Raises Stake in GE HealthCare Technologies Inc. $GEHC

Grandfield & Dodd LLC boosted its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.9% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 332,475 shares of the company’s stock after purchasing an additional 2,827 shares during the period. GE HealthCare Technologies makes up 1.4% of Grandfield & Dodd LLC’s portfolio, making the stock its 23rd largest position. Grandfield & Dodd LLC’s holdings in GE HealthCare Technologies were worth $24,626,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors also recently bought and sold shares of the company. N.E.W. Advisory Services LLC purchased a new stake in GE HealthCare Technologies in the 1st quarter valued at approximately $25,000. Allianz SE grew its position in shares of GE HealthCare Technologies by 165.2% in the second quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after purchasing an additional 218 shares during the last quarter. Gladwyn Financial Advisors Inc. acquired a new position in shares of GE HealthCare Technologies in the second quarter worth $34,000. Game Plan Financial Advisors LLC lifted its holdings in GE HealthCare Technologies by 295.3% in the 2nd quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after purchasing an additional 375 shares in the last quarter. Finally, Zions Bancorporation National Association UT acquired a new stake in shares of GE HealthCare Technologies during the first quarter worth $42,000. Hedge funds and other institutional investors own 82.06% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on GEHC shares. Weiss Ratings reissued a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Tuesday. Morgan Stanley raised their target price on shares of GE HealthCare Technologies from $74.00 to $80.00 and gave the stock an “equal weight” rating in a report on Thursday, October 30th. Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their price target for the company from $93.00 to $83.00 in a report on Tuesday, October 7th. Zacks Research downgraded shares of GE HealthCare Technologies from a “strong-buy” rating to a “hold” rating in a research report on Monday, September 29th. Finally, BTIG Research set a $87.00 price objective on GE HealthCare Technologies in a research note on Wednesday, October 29th. Six equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, GE HealthCare Technologies has a consensus rating of “Moderate Buy” and an average price target of $86.10.

GE HealthCare Technologies Stock Down 1.3%

GE HealthCare Technologies stock opened at $73.97 on Friday. The company has a market capitalization of $33.69 billion, a P/E ratio of 15.28, a P/E/G ratio of 2.82 and a beta of 1.13. The firm’s fifty day simple moving average is $75.20 and its 200-day simple moving average is $73.65. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The company has a current ratio of 1.18, a quick ratio of 0.95 and a debt-to-equity ratio of 0.83.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings data on Wednesday, October 29th. The company reported $1.07 earnings per share for the quarter, beating analysts’ consensus estimates of $1.05 by $0.02. The business had revenue of $5.14 billion for the quarter, compared to the consensus estimate of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.The firm’s revenue was up 5.8% compared to the same quarter last year. During the same period last year, the business earned $1.14 EPS. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. Sell-side analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 14th. Stockholders of record on Friday, October 24th will be issued a dividend of $0.035 per share. The ex-dividend date is Friday, October 24th. This represents a $0.14 dividend on an annualized basis and a dividend yield of 0.2%. GE HealthCare Technologies’s payout ratio is 2.89%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.